Issue 25
Get instant access to latest e-book

latest news


Dec 2016

Saneca to drive R&D Initiative following €1.5 million funding

Contract development and manufacturing organization CDMO Saneca Pharma is driving forward with new research and development initiatives for the manufacture of active pharmaceutical ingredients APIs following a million grant from the Slovak Ministry of Education Science Research and Sport ..


Dec 2016

Aduro Biotech Announces Anti-CD27 Agonist, an Investigational Anti-Cancer Immunotherapy, Advancing in Collaboration with MSD

Aduro Biotech Inc NasdaqADRO a biopharmaceutical company with three distinct immunotherapy technologies announced today that an antiCD antibody developed by Aduro Biotech Europe and derived from its proprietary Bselect technology has been selected to be advanced into clinical development by Merck Co Inc Kenilworth NJ USA known as MSD outside the U..


Dec 2016

Purdue Pharma and AnaBios Collaborate to Advance Research for Non-Opioid, Non-NSAID Treatments for Chronic Pain

Purdue Pharma LP and AnaBios Corporation announced today a collaboration to advance the research of nonopioid nonNSAID compounds for the treatment of chronic pain The goal of the collaboration is to accelerate Purdues Nav sodium ion channel drug candidates utilizing AnaBios PhaseX discovery platform to develop treatmen..


Dec 2016

Global Pharmaceutical Company to invest €40m in Dublin site

Takeda Pharmaceutical Company Limited is to invest m in a new facility at their Grange Castle site in Dublin it was announced today Takeda is the largest pharmaceutical company in Japan and a Global industry leader The company first set up operations in Ireland in manufacturing products for global markets In Takeda ..

events

05 - 07

Dec 2016

Biopharmaceutical Manufacturing Conference

InterContinental Mark Hopkins

05 - 07

Dec 2016

International Conference on Precision Medicine

Conferenceseries LLC
San Antonio, USA


Dec 2016

Puridify and GSK extend evaluation of FibroSelect purification technology

Puridify Limited Puridify developers of novel biop..


  • 1

    Parenteral Preparations

    INTRODUCTION Parenteral preparations are defined as solutions suspensionsemulsions for injection or ..

knowledge bank

  • interviews

    Datwyler Pharma Packaging

    Senior Manager Global Scientific Affairs
    Renaud Janssen, Ph.D. is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging. He frequently presents on international conferences on subjects related to elastomeric and aluminium/plastic closures for pharm..

  • Articles

    Parenteral Preparations

    INTRODUCTION Parenteral preparations are defined as solutions suspensionsemulsions for injection or infusion powders for injection or infusion gels for injection andimplants They are sterile preparations intended to be administrated directly into the systemic circulation in human or animal body They are required like any pharmaceutical dosage forms to meet the pharmaceutical quality standards as ..

  • Research Insights

    Open For Collaboration: An Academic Platform For Drug Discovery And Development At Scilifelab

    Abstract Swedish pharmaceutical industry and research Being a small country with only million inhabitants Sweden has a proud history of successful organic growth of its pharmaceutical industry with companies such as Kabi the first company to license Genentechs recombinant DNA technology later overtaken by Pharmacia subsequently merging with Upjohn and later being closed as a part of Pfizer Hssle bought by Astra and Astra merged with Zeneca to ..

editorial Section

  • Competing on Alignment

    SWOT is both the most powerful and least understood strategic management tool Used correctly it translates the outputs of many other market analyses into a small number of key issues..

  • Future Trends in Ion Channel and Solute Transporter Drug Discovery

    Gene family members of the ion channel and solute transporter SLC families represent both historical targets of pharmaceutical significance and serve as exciting opportunities for current and future therapeutic development The common property of ion movement for many of the SLCs lends itself to considering platforms used in ion channel research to enable early drug discovery In addition the convergence of advances in both genetic analysis and assay technology bodes well for the identification of the next generation of ion channel and transporterbased drugs in the near future..

  • Issues & Concerns in Conducting Clinical Trials in India

    Issues like approval delays deficiencies of functioning of CROs and other stake holders liabilities and compensation to injured subjects insurance issues etc still remain in India which has made multinational companies to rethink on opting for India to conduct clinical trials in India recently There is a need for a law to ensure that the people who undergo clinical trials are not exploited and should be well informed about risk as well to provide..

  • Innovation Challenges in Manufacturing

    Most firms in the pharmaceutical industry think globally to expand demand for their products There are amenities from which firms leverage to launch a strategy to gain global market share These amenities include the regulatory dimension which helps reassign resources within and outside the firm..

  • Quality by Design

    The article presents a novel approach to applying Quality by Design QbD principles to the development of analytical methods Common critical parameters in HPLC gradient time temperature pH of the aqueous eluent and stationary phase are evaluated within the Quality by Design framework It is useful for the robust analytical method development and Design Space optimisation..

  • Peptides Remain a Growth Story

    Cloud solutions offer immediate returns in improving operational performance and reducing costs Multiple approaches to cloud solutions will be needed to satisfy life science industry needs complicating the development of a coherent cloud strategy..